LY96 and type 1 diabetes mellitus: Blockade of TLR4 or MD2 elicited similar results in our ex vivo set of experiments in the aorta of diabetic rats (Fig. 6B), which highlights the TLR4–MD2 complex as an essential modulator of vascular oxidative stress during type 1 diabetes.